Last Exam COPY Flashcards
(159 cards)
- ) What do Biochemical Assays for Metabolic Diseases detect?
- ) When must they be used?
1.) Detects abnormalities caused by any mutant allele that has a significant effect on protein function.
2.) May be the only option if the causative mutation in the family is unknown.
L25 #31
- ) What is the definition of Concordance?
2. ) What is the Rate of Concordance?
1.) When two individuals in a family share a trait or have the same disease.
2.) Proportion of pairs of individuals (e.g. twins) who share a trait or have the same disease.
L22 #18
- ) What is the inheritance pattern for cystic fibrosis?
- ) What is the primary genetic defect?
- ) Most common location of mutation?
- ) What is the function of the mutated gene/protein?
1.) Autosomal recessive
2.) Mutations in cystic fibrosis transmembrane conductance regulator (CFTR) gene –chromosome 7.
3.) ∆F508 is the most common.
4.) CFTR protein functions as a chloride channel, important for salt and water balance – affects multiple organs (e.g. lungs, pancreas).
L20 #31
What is the best method to detect location of mutation in individuals with Duchenne and Becker muscular dystrophy?
Multiplex PCR.
L21 #14
What does the following information tell us about the influences on complex diseases among adopted children:
- ) Increased frequency with adopted family.
- ) Increased frequency in biological family.
1.) Strong evidence for environmental influence in developing the disease.
2.) Strong evidence for genetic contribution to disease.
L22 #13
What are two major drawbacks of Fetal DNA and Fetal Genome Analysis?
1.) When the disorder in the patient is due to a mutation different from the one being sought, i.e. you must know what it is you’re looking for.
2.) May not be predictive of clinical presentation in disorders characterized by variable expressivity (e.g. neurofibromatosis type 1, mitochondrial disorders).
L25 #31, p.729 TT
What are four way that genetic and environmental factors associated with complex diseases are identified? Explain.
1.) Familial risks: Incidence of a disorder in relatives compared with the incidence in the general population.
2.) Twin studies: What is the incidence in monozygotic twins compared with dizygotic twins?
3.) Adoption studies: What is the incidence in adopted children of the disorders which their biological parents had (same genetic background, but different environment)?
4.) Population and migration studies: What is the incidence in people from the same ancestry group when they move to a different geographic area (helps to identify the effect of the environment on the disease).
L22 #12
If an individual has a disease that does not exhibit male-to-male transmission, what other familial inheritance pattern must be observed to confirm the disease inheritance as X-linked?
All daughters of an affected male must also be affected.
L20 #43
- ) Ultrasonography allows detection of structural fetal anomalies associate with which three types of genetic disorders? Give examples of each.
- ) Multiple fetal abnormalities increase the likelihood of a ___________ fetus.
1.)
i.) Single-gene disorders: OI.
ii.) Multifactorial disorders: NTDs, congenital heart defects.
iii.) Specific syndromes: Down and Turner syndrome.
2.) Chromosomally abnormal fetus.
L25 #9
- ) ______ and ________ are essential before prenatal genetic testing.
- ) What is the function of this (what what ISN’T)?
- ) What are three key aspect of this role?
1.) Genetic counseling and informed consent.
2.) To provide information to support decision-making –NOT to dictate course of action
3.) Accurate diagnosis, communication, and non-directive presentation of options.
L25 #47
According to the ACOG (American College of Obstetricians and Gynecologists), what test should be done when structural anomalies are detected on US?
- ) When is it indicated?
- ) Describe the level of genetic information given.
- ) What can it ID?
- ) Limitations (2)?
Chromosomal Microarray Analysis (CMA)
1.) Indicated when structural anomalies are detected on US.
2.) High resolution (yields more information than conventional karyotyping).
3.) Can ID chromosomal aneuploidy, as well as lesions too small to be detected by karyotyping.
4.) Limitations: Detects Variants of Unknown Significance (VUS), as well as adult onset diseases.
L25 #26, p.724 TT
What is the definition of Pharmacogenomics?
Refers to the sum of all relevant genetic information affecting drug therapy.
-Is a much broader investigation of genetic variations at the level of the genome.
L24 #6
During which weeks is α-fetoprotein highest in the fetal plasma, amniotic fluid, and maternal serum?
-Highest in fetal plasma and amniotic fluid at 10 weeks.
-Highest in maternal serum at ≈ 30-40 weeks.
L25 #37
Which parameters used in 1st and 2nd trimester screening tests (4) are seen uniformly increased or decreased among the three major trisomy disorders (trisomy 13, 18, and 21)? Indicate whether increased or decreased and which trimester they are observed.
1.) Nuchal translucency (NT), 1st trimester: Increased
2.) PAPP-A, 2st trimester: Decreased
3.) uE3, 2nd trimester: Decreased
4.) AFP, 2nd trimester: Decreased
L25 #43
Which genes encode for the proteins that allow (a) Green color vision, and (b) Red color vision?
(a) Green: OPN1MW (opsin-1 medium-wave-sensitive).
(b) Red: OPN1LW (opsin-1 long-wave-sensitive).
L21 #20
Oncogenes may be introduced by _____ or ______.
DNA or RNA viruses.
Week 8 review, #4
What is the normal base pair length of CFTR gene on PCR? Abnormal?
Normal = 63 bp
Abnormal = 60 bp
L20 #33
- ) For treatment of adenosine deaminase deficiency (ADA), what is used as a vector for gene therapy?
- ) What are three alternative treatments for ADA?
1.) Retrovirus used as a vector.
2.) BM transplant (matched donor), RBC transfusion from healthy donors, enzyme replacement therapy.
L26 #37
What is the overall purpose of the phase I and phase II reactions of drug metabolism? What happens in each phase?
Phase I and II: Makes drugs more polar and, therefore, more easily excreted by the kidneys.
-Phase I: Oxidation and reduction.
-Phase II: Conjugation reaction.
L24 #11
What is the new aneuploidy screening modality and what is the method?
Non-invasive prenatal screening testing (NIPS), through sequencing of cell-free DNA (cfDNA) in maternal plasma.
L25 #44
Drugs exert their effects by interacting with _________.
Specific target proteins.
L24 #24
In Huntington disease, what is the correlation between the number of repeats and the age of onset? What term applies to this relationship?
More CAG repeats correlated with EARLIER age of onset – This is called “ANTICIPATION.”
L20 #13
What are two limitations that apply to chorionic villus sampling (CVS)?
1.) No amniotic fluid, thus, NTDs cannot be assessed (via [AFP]) – NTD requires AF or maternal serum alpha-fetoprotein levels (MSAFP).
2.) 1% of samples yield ambiguous results due to chromosomal mosaicism, follow up amnio is required.
L25 #15
If all (or almost all) affected individuals are males, and the affected individual does not have an affected parent, what is the inheritance pattern of the disease?
X-linked recessive.
L20 #43